Symptomatic amyloid goiters: Report of five cases

Jennie H. Law, Diana S. Dean, Berndt Scheithauer, Franklin Earnest IV, Thomas J. Sebo, Vahab Fatourechi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Massive amyloid deposition in the thyroid to the point of goiter formation is rare. Here we describe the clinical presentation and outcomes of five patients with amyloid goiter (radiographically confirmed goiter in the context of tissue-proven thyroid amyloidosis) encountered in the past 23 years at our institution. Methods: Mayo Clinic archives were searched between 1987 and 2010 for a diagnosis of "thyroid amyloidosis," "amyloid deposits," "amyloid deposition," or "liquid chromatography consistent with amyloid." Inclusion criteria were symptomatic thyromegaly; tissue confirmation of thyroid enlarged by amyloid deposits; and radiologic confirmation of thyroid enlargement. Results: Five patients were identified who met all inclusion criteria. Amyloid goiter etiology included both primary and secondary amyloidosis, and the goiters ranged in weight from 50 to 130 g each. Diagnosis was made by fine-needle aspiration biopsy with Congo red staining and, if needed, spectrophotometry. All five patients had histories of persistent hoarseness for several years before presentation with compressive symptoms referable to their enlarging thyroids, and all had some degree of thyroid dysfunction (both hypothyroidism and hyperthyroidism) by the end of our follow-up period, which ranged from 5 months to 13 years. Two patients underwent surgical interventions, two were managed conservatively, and in one, the goiter shrank after systemic therapy for amyloidosis. Conclusions: Our clinical observations suggest slower goiter progression and a higher prevalence of thyroid dysfunction than previously thought.

Original languageEnglish (US)
Pages (from-to)1490-1495
Number of pages6
JournalThyroid
Volume23
Issue number11
DOIs
StatePublished - Nov 1 2013

Fingerprint

Goiter
Amyloid
Thyroid Gland
Amyloidosis
Amyloid Plaques
Congo Red
Hoarseness
Spectrophotometry
Hyperthyroidism
Fine Needle Biopsy
Hypothyroidism
Liquid Chromatography
Staining and Labeling
Weights and Measures

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Law, J. H., Dean, D. S., Scheithauer, B., Earnest IV, F., Sebo, T. J., & Fatourechi, V. (2013). Symptomatic amyloid goiters: Report of five cases. Thyroid, 23(11), 1490-1495. https://doi.org/10.1089/thy.2012.0431

Symptomatic amyloid goiters : Report of five cases. / Law, Jennie H.; Dean, Diana S.; Scheithauer, Berndt; Earnest IV, Franklin; Sebo, Thomas J.; Fatourechi, Vahab.

In: Thyroid, Vol. 23, No. 11, 01.11.2013, p. 1490-1495.

Research output: Contribution to journalArticle

Law, JH, Dean, DS, Scheithauer, B, Earnest IV, F, Sebo, TJ & Fatourechi, V 2013, 'Symptomatic amyloid goiters: Report of five cases', Thyroid, vol. 23, no. 11, pp. 1490-1495. https://doi.org/10.1089/thy.2012.0431
Law JH, Dean DS, Scheithauer B, Earnest IV F, Sebo TJ, Fatourechi V. Symptomatic amyloid goiters: Report of five cases. Thyroid. 2013 Nov 1;23(11):1490-1495. https://doi.org/10.1089/thy.2012.0431
Law, Jennie H. ; Dean, Diana S. ; Scheithauer, Berndt ; Earnest IV, Franklin ; Sebo, Thomas J. ; Fatourechi, Vahab. / Symptomatic amyloid goiters : Report of five cases. In: Thyroid. 2013 ; Vol. 23, No. 11. pp. 1490-1495.
@article{d14534b7c58749908a68f103a036a70b,
title = "Symptomatic amyloid goiters: Report of five cases",
abstract = "Background: Massive amyloid deposition in the thyroid to the point of goiter formation is rare. Here we describe the clinical presentation and outcomes of five patients with amyloid goiter (radiographically confirmed goiter in the context of tissue-proven thyroid amyloidosis) encountered in the past 23 years at our institution. Methods: Mayo Clinic archives were searched between 1987 and 2010 for a diagnosis of {"}thyroid amyloidosis,{"} {"}amyloid deposits,{"} {"}amyloid deposition,{"} or {"}liquid chromatography consistent with amyloid.{"} Inclusion criteria were symptomatic thyromegaly; tissue confirmation of thyroid enlarged by amyloid deposits; and radiologic confirmation of thyroid enlargement. Results: Five patients were identified who met all inclusion criteria. Amyloid goiter etiology included both primary and secondary amyloidosis, and the goiters ranged in weight from 50 to 130 g each. Diagnosis was made by fine-needle aspiration biopsy with Congo red staining and, if needed, spectrophotometry. All five patients had histories of persistent hoarseness for several years before presentation with compressive symptoms referable to their enlarging thyroids, and all had some degree of thyroid dysfunction (both hypothyroidism and hyperthyroidism) by the end of our follow-up period, which ranged from 5 months to 13 years. Two patients underwent surgical interventions, two were managed conservatively, and in one, the goiter shrank after systemic therapy for amyloidosis. Conclusions: Our clinical observations suggest slower goiter progression and a higher prevalence of thyroid dysfunction than previously thought.",
author = "Law, {Jennie H.} and Dean, {Diana S.} and Berndt Scheithauer and {Earnest IV}, Franklin and Sebo, {Thomas J.} and Vahab Fatourechi",
year = "2013",
month = "11",
day = "1",
doi = "10.1089/thy.2012.0431",
language = "English (US)",
volume = "23",
pages = "1490--1495",
journal = "Thyroid",
issn = "1050-7256",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - Symptomatic amyloid goiters

T2 - Report of five cases

AU - Law, Jennie H.

AU - Dean, Diana S.

AU - Scheithauer, Berndt

AU - Earnest IV, Franklin

AU - Sebo, Thomas J.

AU - Fatourechi, Vahab

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Background: Massive amyloid deposition in the thyroid to the point of goiter formation is rare. Here we describe the clinical presentation and outcomes of five patients with amyloid goiter (radiographically confirmed goiter in the context of tissue-proven thyroid amyloidosis) encountered in the past 23 years at our institution. Methods: Mayo Clinic archives were searched between 1987 and 2010 for a diagnosis of "thyroid amyloidosis," "amyloid deposits," "amyloid deposition," or "liquid chromatography consistent with amyloid." Inclusion criteria were symptomatic thyromegaly; tissue confirmation of thyroid enlarged by amyloid deposits; and radiologic confirmation of thyroid enlargement. Results: Five patients were identified who met all inclusion criteria. Amyloid goiter etiology included both primary and secondary amyloidosis, and the goiters ranged in weight from 50 to 130 g each. Diagnosis was made by fine-needle aspiration biopsy with Congo red staining and, if needed, spectrophotometry. All five patients had histories of persistent hoarseness for several years before presentation with compressive symptoms referable to their enlarging thyroids, and all had some degree of thyroid dysfunction (both hypothyroidism and hyperthyroidism) by the end of our follow-up period, which ranged from 5 months to 13 years. Two patients underwent surgical interventions, two were managed conservatively, and in one, the goiter shrank after systemic therapy for amyloidosis. Conclusions: Our clinical observations suggest slower goiter progression and a higher prevalence of thyroid dysfunction than previously thought.

AB - Background: Massive amyloid deposition in the thyroid to the point of goiter formation is rare. Here we describe the clinical presentation and outcomes of five patients with amyloid goiter (radiographically confirmed goiter in the context of tissue-proven thyroid amyloidosis) encountered in the past 23 years at our institution. Methods: Mayo Clinic archives were searched between 1987 and 2010 for a diagnosis of "thyroid amyloidosis," "amyloid deposits," "amyloid deposition," or "liquid chromatography consistent with amyloid." Inclusion criteria were symptomatic thyromegaly; tissue confirmation of thyroid enlarged by amyloid deposits; and radiologic confirmation of thyroid enlargement. Results: Five patients were identified who met all inclusion criteria. Amyloid goiter etiology included both primary and secondary amyloidosis, and the goiters ranged in weight from 50 to 130 g each. Diagnosis was made by fine-needle aspiration biopsy with Congo red staining and, if needed, spectrophotometry. All five patients had histories of persistent hoarseness for several years before presentation with compressive symptoms referable to their enlarging thyroids, and all had some degree of thyroid dysfunction (both hypothyroidism and hyperthyroidism) by the end of our follow-up period, which ranged from 5 months to 13 years. Two patients underwent surgical interventions, two were managed conservatively, and in one, the goiter shrank after systemic therapy for amyloidosis. Conclusions: Our clinical observations suggest slower goiter progression and a higher prevalence of thyroid dysfunction than previously thought.

UR - http://www.scopus.com/inward/record.url?scp=84885368435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885368435&partnerID=8YFLogxK

U2 - 10.1089/thy.2012.0431

DO - 10.1089/thy.2012.0431

M3 - Article

C2 - 23544771

AN - SCOPUS:84885368435

VL - 23

SP - 1490

EP - 1495

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 11

ER -